French Prime Minister Visits Ceva Santé Animale

FRANCE - French Prime Minister Manuel Valls has visited Ceva’s headquarters in Libourne, to meet Dr Marc Prikazsky and other business leaders from the local Aquitaine region.
calendar icon 24 July 2015
clock icon 3 minute read

The Prime Minister was accompanied by a large delegation including Alain Rousset, President of the Aquitaine region.

The company has recently invested over €20 million in its Libourne site to ensure its infrastructure is of the best available global standard.

For Marc Prikazsky, Ceva Santé Animale CEO, "The visit of the Prime Minister is I believe recognition for the dynamism of the French veterinary sector. Collectively we represent 20 per cent of the world market.

"Ceva stands out in this sector because of its unique shareholder structure, which has helped us to deliver double digit growth for more than a decade. Hopefully, we have show that it is possible to grow and do business internationally while continuing to invest heavily in France. I believe in Europe’s industrial future because we have highly trained people and all the skills necessary to succeed, provided we continue to invest in state of the art facilities to remain globally competitive."

An encounter with midcaps

The Prime Minister’s visit to Ceva also included a meeting with business leaders who are members of the Aquitaine Intermediate-Sized Business Club chaired by Dr Prikazsky.

The Club is the only one of its kind in France and currently counts 42 business leaders from the industrial and corporate services sector based in the Aquitaine region. Together, they have combined sales of €5.5 billion and employ over 30,000 people.

Key Figures: Ceva Santé Animale in France and in Libourne

  • Over 3,750 employees around the world
  • More than 1,100 in France
  • 670 at headquarters in Libourne, including 130 in the new production facility
  • R&D expenditure: almost 10% of turnover
  • Innovation: over 500 people
  • Production: products to treat diseases (pharmaceutical products) represent 2/3 of activity and prevention products (vaccines…) 1/3 of activity
  • A unique model: management and employees have bought out the company and hold 2/3 of its shares
Prime Minister Manuel Valls visits Ceva with Marc Prikazsky
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.